Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-05-05 | Thyroid hormone diagnostics 1 | ETA2023

Multicenter, 5-assay comparison of thyrotropin receptor blocking antibodies

George Augustine , Bossowski Artur , Frommer Lara , Hatun Burak , Konig Jochem , Lupo Mark , Wolf Jan , Kahaly George

Background: Thyrotropin receptor (TSH-R) blocking autoantibodies (TBAb) are present in 10-15% of patients with autoimmune thyroid disease (AITD). TBAb are functional and clinically relevant. This multicenter study compares the sensitivity and specificity of five immunoassays for the measurement of TBAb and introduces a novel and ultra-rapid TBAb bioassay.Methods: Serum samples from AITD patients were tested with two TSH-R binding immunoassays (Cobas e411...

ea0077oc1.6 | Reproductive and Neuroendocrinology | SFEBES2021

Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates

Johnson Gillian , Onabanjo Caitlan , Bousfield George , Hardy Kate , Jonas Kim

Ovarian ageing is a naturally occurring physiological process, marked by dynamic changes in ovarian function and hormone secretion. A key endocrine regulator of ovarian function is the heterodimeric glycoprotein hormone, follicle stimulating hormone (FSH). FSH is secreted as two glycosylation variants: partially glycosylated FSH (FSH21) and fully glycosylated FSH (FSH24). These variants have different in-vitro activities, with FSH21 more bioactive than FSH24. Interest...

ea0077p102 | Reproductive Endocrinology | SFEBES2021

Differentially glycosylated FSHR ligands as potential modulators of FSHR quaternary complexes and FSHR-dependent signalling

Agwuegbo Uche , Colley Emily , Bousfield George , Albert Anthony , Jonas Kim

The G protein-coupled receptor, follicle-stimulating hormone receptor (FSHR), is essential for reproduction. A key drug target of IVF, understanding the mechanisms modulating FSHR functions remains of high importance. The endogenous ligand of the FSHR, FSH, is a heterodimeric glycoprotein hormone with two predominant glycoforms identified. Partially glycosylated FSH21 has faster binding kinetics to the FSHR and more potent at activating cAMP-dependent signal pathways, in compa...

ea0081oc1.2 | Oral Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2022

Glucose control and mortality in critically Ill patients, based on real world evidence

Dafoulas George , Kalamaras Ilias , Votis Konstantinos , Bargiota Alexandra

Objective: Published results of reduced morbidity and mortality with tight Glycemic Control of critical patients could not be reproduced in large prospective trials. Glycemic goals according to current respective guidelines include a target blood glucose range 140-180 mg/dl, while lower blood glucose targets may be appropriate for some patients. This study aims to provide real world evidence to this field.Methods: We performed a retrospective study using...

ea0081oc3.1 | Oral Communications 3: Thyroid 1 | ECE2022

Real world prospective application of ATA guidelines in over 500 aspirated thyroid nodules: Is it time for changing the size cut-offs for FNA?

Ioakim Stamatina , Zavros George , Picolos Michalis , Syed Akheel , Kyriacou Angelos

Introduction: The 2015 American Thyroid Association (ATA) guidelines on the management of thyroid nodules and cancer recommend specific size cut-offs for fine needle aspiration (FNA) cytology. We assessed the correlation between sonographic and cytological stratification as per the guidelines, with emphasis on the size cut-offs.Methods: In a ‘real world’ prospective study, we sonographically stratified 562 thyroid nodules prior to performing ul...

ea0081p212 | Thyroid | ECE2022

Identifying the use of clinical and radiological parameters to assess moderate-severe Graves’ Orbitopathy − a multi-centre analysis of the characteristics of patients with Graves’ Orbitopathy

George Nicole , Lee Vickie , Feeney Claire , Bhatia Kunwar , Ali Amina

Background: Early diagnosis and surveillance of Graves’ Orbitopathy (GO) is essential to prevent severe, sight-threatening complications and long-term disability; therefore, it is highly desirable to identify risk factors and early predictors of severe disease. GO is clinically assessed using the Clinical Activity Score (CAS) and the EUGOGO Severity Scale (ESS), which are subjective, qualitative tests that are used to evaluate the activity and severity at the anterior orb...

ea0081p732 | Thyroid | ECE2022

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in advanced thyroid cancer (TC) patients; single-center experience

Simeakis George , Paschou Stavroula A. , Alevizaki Maria , Saltiki Katerina

Objectives: Patients suffering from pulmonary or/and neoplastic disease are at higher risk of developing serious illness from SARS-CoV-2. TC patients with lung metastases are classified as high-risk for severe CoV-2 disease. Aim of this study was to investigate SARS-CoV-2 prevalence and severity in this particular subgroup of patients.Methods: Out of 28 patients with metastatic Differentiated Thyroid Cancer (DTC) and 21 patients with met...

ea0081p733 | Thyroid | ECE2022

Increased incidence of primary hyperparathyroidism in patients with papillary thyroid cancer. Just a coincidence or a new syndrome. 

Papadopoulou-Marketou Nektaria , Chrousos George , Tsiamyrtzis Panagiotis , Karvounis Evaggelos

Presence of primary hyperparathyroidism (PHPT) in patients with thyroid disease has been previously reported. However, co-existence of PTHPT and papillary thyroid cancer (PTC) has been reported very rarely, mainly in the form of isolated case reports. Since the pathophysiological mechanisms of the two diseases are theoretically quite different, no causal relation between these diseases has been inferred. The aim of this study was to investigate the presence of PHTP in individu...

ea0081ep848 | Pituitary and Neuroendocrinology | ECE2022

Chronic diarrhea: the diagnostic process

Floroskoufi Paraskevi , Vourlioaki Eirini , George Papazoglou , Koukias Stergos , Stamataki Aikaterini

Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of rare neoplasms that originate from endocrine cells with the ability to secrete amines and hormonal polypeptides. Pancreatic neuroendocrine tumors (PNETs) can be functional or non-functional. Functional PNETs secrete common hormones such as gastrin, insulin and glucagon and much less frequent hormones such as vasoactive intestinal peptide (VIP). Their clinical characteristics depend on the peptide secreted....

ea0050oc5.3 | Reproduction and Neuroendocrinology | SFEBES2017

Decoding the functional significance of follicle stimulating hormone glycosylation variants

Colley Emily , Wakefield Baylee , Bousfield George , Jonas Kim

FSH and its G protein-coupled receptor (FSHR) are essential for the coordination of reproductive functions. As such, they are a primary target of most assisted reproductive technologies, thus understanding the physiology regulating their function is paramount. Two naturally occurring glycoforms of FSH have been identified-hyperglycosylated FSH (FSH24) and hypoglycosylated FSH (FSH21), based on their ASN glycosylation pattern. The secretion of FSH21 and FSH24 has been shown to ...